Global genital herpes treatment market will reach $5,051.8 million by 2032, growing by 4.7% annually over 2022-2032, driven by the rising prevalence of sexually transmitted diseases, changing ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 32 tables and 44 figures, this 110-page report ?Asia Pacific Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1 ...

The research offers exciting potential ... Dec. 23, 2024 — The standard medication levodopa does not always work against tremors in Parkinson's disease, especially in stressful situations.

The Target-MRD blood test uses a combination of tumor-informed and tumor-agnostic molecular features for personalized, accurate and more effective monitoring of molecular residual disease.

But this is declining by about 2% each year while new genital infections that result from HSV-1 are rising. Genital herpes causes a substantial disease ... is now so common, testing is not usually ...

While LRRK2 GTPase is a crucial target for Parkinson's Disease research, it is difficult to selectively modulate GTPases with drugs. Further, one part of the GTPase domain, the COR domain ...

A molecular diagnostics start-up founded by former IISc professor and biotech entrepreneur Vijay Chandru has recently opened a laboratory in Bengaluru for developing diagnostics for rare diseases like ...

But the ramifications of the research could go even further, applying to a range of similar diseases that affect thousands of Australians such as Fragile X syndrome and Friedreich's ataxia.

The nontreponemal tests include the Venereal Disease Research Laboratory test and rapid plasma reagin. Nontreponemal test titers usually correlate with disease activity. False positives can occur ...

The research laboratories are located in the west wing of the S. J. Sarkeys Complex and in the Collums Building. The laboratories in the Sarkeys Complex occupy about 4,000 sq. ft. of combined space ...

Cerebrospinal (CSF) analysis showed no pleocytosis and results of a Venereal Disease Research Laboratory (VDRL) test of CSF were nonreactive. He was treated for late latent syphilis without ...